GSK Plc (GSK)
50.37
-0.29
(-0.57%)
USD |
NYSE |
Sep 02, 14:33
GSK Research and Development Expense (Annual) : 8.171B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 8.171B |
| December 31, 2024 | 7.024B |
| December 31, 2023 | 6.520B |
| December 31, 2022 | 5.957B |
| December 31, 2021 | 6.032B |
| December 31, 2020 | 5.744B |
| December 31, 2019 | 5.416B |
| December 31, 2018 | 4.878B |
| December 31, 2017 | 4.977B |
| December 31, 2016 | 4.685B |
| December 31, 2015 | 5.225B |
| December 31, 2014 | 5.491B |
| December 31, 2013 | 5.381B |
| December 31, 2012 | 5.525B |
| December 31, 2011 | 5.907B |
| December 31, 2010 | 6.642B |
| December 31, 2009 | 6.235B |
| December 31, 2008 | 6.598B |
| Date | Value |
|---|---|
| December 31, 2007 | 6.516B |
| December 31, 2006 | 6.364B |
| December 31, 2005 | 5.698B |
| December 31, 2004 | 5.318B |
| December 31, 2003 | 4.559B |
| December 31, 2002 | 4.100B |
| December 31, 2001 | 3.678B |
| December 31, 2000 | 3.797B |
| December 31, 1999 | 3.697B |
| December 31, 1998 | 1.927B |
| December 31, 1997 | 1.880B |
| December 31, 1996 | 1.811B |
| December 31, 1995 | 1.891B |
| June 30, 1994 | 1.285B |
| June 30, 1993 | 0.00 |
| June 30, 1992 | 0.00 |
| June 30, 1991 | 878.92M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| AstraZeneca PLC | 13.84B |
| Eli Lilly & Co. | 13.34B |
| Merck & Co., Inc. | 12.51B |
| Pfizer Inc. | 10.25B |
| Sanofi | 8.845B |